Created in 1993, Quantel Medical is a fully owned subsidiary of the Lumibird Group. Its core activities are the development, manufacturing and commercialization of innovative solutions in medical lasers and ultrasound technologies. Present in over 110 countries either direct or through distributors, Quantel Medical has become a world leader in the ophthalmic field. We address the needs of ophthalmologists to diagnose and treat patients affected by the four major causes of blindness: cataract, glaucoma, diabetic retinopathy and macular degeneration. Since 2018, Quantel Medical also offers a complete range of diagnosis and treatment of the dry eye syndrome. With the acquisition of the ECM medical business, Quantel Medical has also entered into the market of general ultrasound systems for point-of-care, musculoskeletal and various other medical specialties. More information in our website!